Proteins

Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors

ISS National Lab helps fuel the development of groundbreaking treatment for all types of cancer and beyond

Factor previously known to play a role in advanced cancer is fundamental in early stages of cancer development

Researchers studied whether two biomarkers could predict recurrence in head and neck cancer

Alongside other laboratory tests, Freelite assays are used as part of a workflow for diagnosing and monitoring monoclonal gammopathies

The new platform will help researchers better understand cell-to-cell interactions in tumor microenvironments, benefitting future development of targeted cancer therapies

The preservative reagent in Protein Plus BCT™ maintains sample integrity during storage, shipping, and handling

Tuberculosis is the world's deadliest infectious disease and kills more than 1 million people each year, per the WHO

Per the NIH, head and neck cancer makes up about 5 percent of all cancers worldwide and 3 percent of all malignancies in the US

High levels of IFN-γ persisted in some long COVID patients for up to 31 months, making it a reliable biomarker